期刊文献+

肾移植后早期血清脂质紊乱与免疫抑制剂的关系

Correlation between early stage disorder of serum lipid and immunosuppressant in renal transplant patients
暂未订购
导出
摘要 背景:肾移植后早期约有2/3以上患者伴有高脂血症,其是慢性移植肾病以及移植后肾失功的重要危险因素。目的:分析肾移植后早期患者血清脂质紊乱的特点。设计、时间及地点:病例-对照观察,于2004-05/2006-05在郑州大学第一附属医院完成。对象:选择肾移植后患者84例,另外选择同期门诊健康体检者49例作为对照。方法:84例肾移植患者根据志愿原则和经济条件选择不同免疫抑制剂治疗方案。环孢素A组53例,他克莫司组31例。根据环孢素A组患者服药期间平均环孢素A峰浓度分组,将环孢素A峰浓度≥852.611μg/L设定为高环孢素A峰浓度组(n=22),〈852.61μg/L为低环孢素A峰浓度组(n=31)。主要观察指标:分别于肾移植前和移植后3,6,12个月检测患者各项血清脂质指标水平,并与同期健康体检者进行对比。结果:①肾移植组移植后多数时间血清总胆固醇、三酰甘油和低密度脂蛋白胆固醇指标明显高于移植前和对照组(P〈0.05-0.01),高密度脂蛋白胆固醇则明显低于移植前和对照组(P〈0.05—0.01)。②环孢素A组移植后大部分时间血清总胆固醇、三酰甘油和低密度脂蛋白胆固醇水平均明显高于移植前和他克莫司组(P〈0.05~0.01),高密度脂蛋白胆固醇则明显低于移植前和他克莫司组(P〈0.05~0.01)。③高环孢素A峰浓度组移植后大部分时间血清总胆固醇、三酰甘油和低密度脂蛋白胆固醇水平均明显商于移植前和低环孢素A峰浓度组(P〈0.05~0.01),高密度脂蛋白胆固醇则明显低于移植前和低环孢素A峰浓度组(P均〈0.05-0.01)。结论:肾移植后早期患者存在着明确的血清脂质紊乱.与使用环孢素A类免疫抑制药物及其血药峰浓度密切相关。 BACKGROUND: About 2/3 of renal transplant recipients are accompanied with hyperlipemia, which is an important risk factor of chronic transplant nephropathy and renal dysfunction after transplantation. OBJECTIVE: To analyze patients' characteristics of early stage disorder of serum lipid after transplant. DESIGN, TIME AND SETTING: A case-controlled observation was performed in the First Affiliated Hospital of Zhengzhou University from May 2004 to May 2006. PARTICIPANTS: Totally 84 renal transplant recipients and 49 health examinees were recruited in this study. METHODS: According to the patient's will and economics condition, 53 of 84 cases were treated with ciclosporin A, including high concentration group (n=22) of ≥852.61 μ g/L and low concentration group (n=31) of 〈 852.61 μ g/L, while other 31 of 84 cases were treated with tacrolimus. MAIN OUTCOME MEASURES: The serum lipids in 84 renal transplant recipients were determined before transplantation and 3, 6 and 12 months after transplantation, and compared with persons receiving health examination in the corresponding period. RESULTS: The levels of triacylglycerol (TG), total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C) in renal transplant recipients after transplantation were clearly higher than before transplantation and in the control group (P 〈 0.05-0.01). High density lipoprotein cholesterol (HDL-C) levels were clearly lower than before transplantation and in the control group (P 〈 0.05-0.01). Most of detection values ofTG, TC and LDL-C in the ciclosporin A group after transplantation were clearly higher than before transplantation and that in the tacrolimus group (P 〈 0.05-0.01). HDL-C values were clearly lower than before transplantation and that in the tacrolimus group (P 〈 0.05-0.01). Most of detection values of TG, TC and LDL-C in the high peak concentrations of ciclosporin A group after transplantation were clearly higher than before transplantation and that in the low peak concentrations group (P 〈 0.05-0.01). HDL-C values were clearly lower than before transplantation and that in the low peak concentrations group (P 〈 0.05-0.01). CONCLUSION: Renal transplant recipients have obvious early stage disorder of serum lipid. The disorder is closely related to the use of ciclosporin A immunosuppressants and blood concentration of ciclosporin A.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2008年第40期7829-7832,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献26

  • 1Siirtola A, Virtanen SM, Ala-Houhala M, et al. Diet does not explain the high prevalence of dyslipidaemia in paediatric renal transplant recipients. Pediatr Nephrol 2008;23(2):297-305
  • 2Wang YX, Lu YS, Xu QJ, et al. Zhonghua Shenzangbing Zazhi 2004;20(1): 61-62
  • 3舒春兰,周临生,雷小勇,成元桂.氟伐他汀对高脂血症患者的血脂及细胞粘附分子的影响[J].中国动脉硬化杂志,2002,10(1):62-64. 被引量:25
  • 4Kimak E, Ksiazek A, Baranowicz-Gaszczyk I, et al. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients. Ren Fail 2007;29(6):705-712
  • 5Zhu QG, Z-hao YK. Linchuang Waike Zazhi 2007; 15(2): 128-129
  • 6祝清国,赵亚昆.肾移植术后高脂血症[J].临床外科杂志,2007,15(2):128-129. 被引量:1
  • 7Han CH, He CM. Guowai Yixue: Qiguan Yizhi Fence 2002;2(2):40-44
  • 8韩从辉 何长民.肾脏移植新逝展.国外医学:器官移植分册,2002,2(2):40-44.
  • 9Wang XH. Shanghai Mianyixue Zazhi 2002;22(4): 220:224
  • 10覃军,李爱民,何作云.他汀类药物对血管平滑肌细胞的直接作用及其意义[J].中国动脉硬化杂志,2000,8(4):373-375. 被引量:17

二级参考文献89

  • 1王长希,尚文俊,陈立中,费继光,邱江,郑克立.雷帕霉素对肾移植受者血脂的影响[J].肾脏病与透析肾移植杂志,2004,13(3):222-225. 被引量:8
  • 2姜会庆,易学明,李元新,胡心宝,李幼生,汪涌,汪军,孙东燕,陈一飞,黎介寿.同种异体复合组织移植术后免疫抑制剂的应用[J].医学研究生学报,2005,18(4):373-374. 被引量:4
  • 3张春妮,樊璐,汪俊军.低水平高密度脂蛋白胆固醇患者治疗的研究进展[J].医学研究生学报,2006,19(1):84-88. 被引量:4
  • 4Laufs U,JBiolChem,1998年,37卷,273期,24,266页
  • 5Tse KC, Lam MF, Yip PS, et al. A long-term study on hyperlipidemia in stable renal transplant recipients. Clin Transplant, 2004, 18(3): 274 -280.
  • 6Bilchick KC, Henrikson CA, Skojec D, et al. Treatment of hyperlipidemia in cardiac transplant recipients. Am Heart J,2004,148(2):200-210.
  • 7Silverstein DM. Risk factors for caediovascular disease in pediatric renal transplant recipients. Pediatr Transplant, 2004,8(4): 386 - 393.
  • 8Angeles C, Lane BP, Miller F, et al. Fenofibrate- associated reversible acute allograft dysfunction in 3 renal transplant recipients: biopsy evidence of tubular toxicity. Am J Kidney Dis,2004,44(3):543 - 550.
  • 9Castello IB. Hyperlipidemia: a risk factor for chronic allograft dysfunction.Kidney Int Suppl,2002,80:73-77.
  • 10Kahraman S, Kiykim AA, Altum B, et al. Apolipoprotein E gene polymorphism in renal transplant recipients: effects on lipid metabolism,atherosclerosis and allograft function. Transplant, 2004, 18(3): 288-294.

共引文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部